Teva Pharmaceutical Statistics
Total Valuation
TEVA has a market cap or net worth of $18.74 billion. The enterprise value is $35.69 billion.
| Market Cap | 18.74B |
| Enterprise Value | 35.69B |
Important Dates
The next estimated earnings date is Wednesday, July 31, 2024, before market open.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TEVA has 1.13 billion shares outstanding.
| Shares Outstanding | 1.13B |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 52.07% |
| Float | 1.13B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5.59 |
| PS Ratio | 1.17 |
| Forward PS | 1.15 |
| PB Ratio | 2.58 |
| P/FCF Ratio | 21.35 |
| PEG Ratio | 1.84 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.82, with an EV/FCF ratio of 40.65.
| EV / Earnings | n/a |
| EV / Sales | 2.23 |
| EV / EBITDA | 21.82 |
| EV / EBIT | 69.30 |
| EV / FCF | 40.65 |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 2.74.
| Current Ratio | 0.89 |
| Quick Ratio | 0.47 |
| Debt / Equity | 2.74 |
| Debt / EBITDA | 12.19 |
| Debt / FCF | 22.71 |
| Interest Coverage | 0.49 |
Financial Efficiency
Return on equity (ROE) is -6.90%.
| Return on Equity (ROE) | -6.90% |
| Return on Assets (ROA) | -1.20% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $422,816 |
| Profits Per Employee | -$13,025 |
| Employee Count | 37,851 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.03 |
Taxes
| Income Tax | -39.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +121.26% in the last 52 weeks. The beta is 0.91, so TEVA's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | +121.26% |
| 50-Day Moving Average | 15.98 |
| 200-Day Moving Average | 12.37 |
| Relative Strength Index (RSI) | 50.94 |
| Average Volume (20 Days) | 8,850,438 |
Short Selling Information
| Short Interest | 24.56M |
| Short Previous Month | 13.00M |
| Short % of Shares Out | 1.79% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.62 |
Income Statement
In the last 12 months, TEVA had revenue of $16.00 billion and -$493.00 million in losses. Loss per share was -$0.44.
| Revenue | 16.00B |
| Gross Profit | 7.83B |
| Operating Income | 215.00M |
| Pretax Income | -532.00M |
| Net Income | -493.00M |
| EBITDA | 1.64B |
| EBIT | 515.00M |
| Loss Per Share | -$0.44 |
Balance Sheet
The company has $2.99 billion in cash and $19.94 billion in debt, giving a net cash position of -$16.95 billion or -$14.96 per share.
| Cash & Cash Equivalents | 2.99B |
| Total Debt | 19.94B |
| Net Cash | -16.95B |
| Net Cash Per Share | -$14.96 |
| Equity (Book Value) | 7.28B |
| Book Value Per Share | 6.43 |
| Working Capital | -1.50B |
Cash Flow
In the last 12 months, operating cash flow was $1.39 billion and capital expenditures -$511.00 million, giving a free cash flow of $878.00 million.
| Operating Cash Flow | 1.39B |
| Capital Expenditures | -511.00M |
| Free Cash Flow | 878.00M |
| FCF Per Share | $0.78 |
Margins
Gross margin is 48.95%, with operating and profit margins of 1.34% and -3.08%.
| Gross Margin | 48.95% |
| Operating Margin | 1.34% |
| Pretax Margin | -3.32% |
| Profit Margin | -3.08% |
| EBITDA Margin | 10.22% |
| EBIT Margin | 3.22% |
| FCF Margin | 5.49% |
Dividends & Yields
TEVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.72% |
| Shareholder Yield | -0.72% |
| Earnings Yield | -2.63% |
| FCF Yield | 4.68% |
Analyst Forecast
The average price target for TEVA is $17.00, which is 2.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.00 |
| Price Target Difference | 2.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 1, 2004. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 1, 2004 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
TEVA has an Altman Z-Score of 0.24 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.24 |
| Piotroski F-Score | 5 |